title: Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia.
authors.affiliation: Abteilung für Hämatologie und Onkologie Medizinische Hochschule Hannover, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Freund
authors.forename: F
authors.initials: F
authors.lastname: Hild
authors.forename: A
authors.initials: A
authors.lastname: Grote-Metke
authors.forename: R
authors.initials: R
authors.lastname: Nowak
authors.forename: B
authors.initials: B
authors.lastname: Otremba
authors.forename: B
authors.initials: B
authors.lastname: Wörmann
authors.forename: O
authors.initials: O
authors.lastname: Koch
authors.forename: M
authors.initials: M
authors.lastname: Dohmen
authors.forename: H D
authors.initials: HD
authors.lastname: Kleine
authors.forename: H
authors.initials: H
authors.lastname: Link
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012074:Remission Induction
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D003561:Cytarabine; D002066:Busulfan